It prompts you to report your current weight, any side effects experienced, medications changes, and overall progress
Patients should not stop taking prescribed medication without first consulting a healthcare provider, as abrupt changes can pose additional risks
Rye P, Modi R, Cawsey S, Sharma AM
As interest in obesity and metabolic disorders increased, Cagrilintide became a valuable research compound for exploring the complex biology of energy regulation
[PMID: 39480405] PubMed record related to this compound for laboratory literature review
Compare this to the indefinite treatment paradigm of pharmaceutical GLP-1 medications, where the expectation is continuous use and discontinuation typically leads to rebound